| Literature DB >> 35566068 |
Ibrahim Ahmed Shaikh1, Uday M Muddapur2, Zabin K Bagewadi2, Sneha Chiniwal2, Mohammed M Ghoneim3,4, Mater H Mahnashi5, Fahad Alsaikhan6, Deepak Yaraguppi2, Francois N Niyonzima7, Sunil S More8, Basheerahmed Abdulaziz Mannasaheb3, Amer Al Ali9, Abdulaziz Asiri10, Aejaz Abdullatif Khan11, S M Shakeel Iqubal11.
Abstract
The applications of bioactive compounds from medicinal plants as therapeutic drugs are largely increasing. The present study selected the bioactive compounds from Acacia concinna (A. concinna) and Citrus limon (C. limon) to assess their phytochemicals, proteins, and biological activity. The plant material was collected, and extraction performed as per the standard procedure. Qualitative analysis was undertaken, and identification of functional organic groups was performed by FTIR and HPLC. Antibacterial, anticancer, antioxidant, antihyperglycemic, antihyperlipidemic, and inhibition kinetics studies for enzymes were performed to assess the different biological activities. Flavonoids and phenols were present in a significant amount in both the selected plants. A. concinna showed significant antimicrobial activity against Z. mobilis, E. coli, and S. aureus, with minimum inhibition zones (MIZ) of 24, 22, and 20 mm, respectively. C. limon strongly inhibited all the tested pathogenic bacteria with maximum and minimum MIZ of 32 and 17 mm. A. concinna silver nanoparticles also exhibited potent antimicrobial activity. Both extracts showed substantial antioxidant, antihyperlipidemic, antidiabetic, anticancer (MCF-7), and anti-urease (antiulcer) properties. To conclude, these plants can be used to treat hyperlipidemia, diabetes, cancer, and gastrointestinal ulcers. They can also serve as antimicrobial and antioxidant agents. Thus, the studied plants must be exploited cost-effectively to generate therapeutic drugs for various diseases.Entities:
Keywords: Acacia concinna; Citrus limon; anticancer; antidiabetic; medicinal plants; phytochemical screening
Mesh:
Substances:
Year: 2022 PMID: 35566068 PMCID: PMC9105112 DOI: 10.3390/molecules27092715
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Phytochemicals observed in A. concinna and C. limon after methanol extraction. +: present, −: absent.
| Phytoconstituents |
|
|
|---|---|---|
| Alkaloids | + | + |
| Flavonoids | + | + |
| Saponins | + | + |
| Steroids and triterpenoids | + | + |
| Tannins | + | + |
| Phenols | + | + |
| Glycosides | + | + |
| Quinones | + | + |
| Coumarins | + | + |
| Diterpenes | − | + |
| Phlobatannins | + | + |
| Anthocyanosides | + | + |
| Catechins | − | − |
Concentration of some phytochemicals observed from plant extracts.
| Medicinal Plant | Alkaloids (mg/L) | Flavonoids (mg/L) | Phenols (mg/L) |
|---|---|---|---|
|
| 0.1860 ± 0.0001 | 0.2768 ± 0.0003 | 0.2431 ± 0.0002 |
|
| 0.0002 ± 0.0000 | 0.1752 ± 0.0001 | 0.3401 ± 0.0007 |
Figure 1FTIR analysis of phytochemicals in the plant extracts. (A) FTIR trace of Citrus limon; (B) FTIR trace of Acacia concinna.
Figure 2HPLC chromatograph of quercetin from A. concinna extract. The pink coloured lines represent the retention/peak values.
Figure 3HPLC chromatograph of vanillin, quercetin, gallic acid, and caffeine from C. limon extract. The pink coloured lines represent the retention/peak values.
Zone of bacterial clearance of various extracts in mm.
| Medicinal Plant |
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
| 22 ± 0.763 | 7 ± 0.123 | 24 ± 0.801 | 7 ± 0.285 | 20 ± 0.365 | 5 ± 0.169 | 5 ± 0.401 |
|
| 22 ± 0.671 | 17 ± 0.249 | 22 ± 0.593 | 32 ± 0.582 | 27 ± 0.801 | 22 ± 0.467 | 21 ± 0.397 |
MIC of A. concinna and C. limon at 600 nm.
|
|
|
|
|
|
|
|
| 50 µg/mL | − | − | − | − | − | − |
| 100 µg/mL | − | − | − | − | − | − |
| 150 µg/mL | − | − | − | − | − | − |
|
| ||||||
| 50 µg/mL | + | − | − | + | − | − |
| 100 µg/mL | − | − | − | − | − | − |
| 150 µg/mL | − | − | − | − | − | − |
Figure 4Incubation of silver nitrate solution with A. concinna leaf extract.
Figure 5UV–vis spectrum showing formation of silver nanoparticles.
Figure 6Antimicrobial activity of synthesized nanoparticles by A. concinna extract against Z. mobilis.
Anticancer activity of A. concinna extract.
| Blank | Untreated | Cisplatin 15 µg/mL | 100 | 200 | 300 | 400 | 500 µg/mL | |
|---|---|---|---|---|---|---|---|---|
| Reading 1 | 0.009 | 0.63 | 0.068 | 0.375 | 0.229 | 0.19 | 0.011 | 0.007 |
| Reading 2 | 0.005 | 0.69 | 0.068 | 0.387 | 0.202 | 0.172 | 0.017 | 0.009 |
| Mean OD | 0.007 | 0.685 | 0.068 | 0.381 | 0.2155 | 0.181 | 0.014 | 0.008 |
| Mean OD-Mean blank | 0.678 | 0.0681 | 0.374 | 0.2085 | 0.174 | 0.007 | 0.001 | |
| Standard deviation | 0.0169706 | 0 | 0.008485 | 0.019092 | 0.012728 | 0.004243 | 0.001414 | |
| Standard Error | 0.012 | 0 | 0.006 | 0.0135 | 0.009 | 0.003 | 0.001 | |
| % Standard error | 1.7699115 | 0 | 0.884956 | 1.99115 | 1.327434 | 0.442478 | 0.1474 | |
| % Viability | 100 | 8.997050 | 55.16224 | 30.75221 | 25.66372 | 1.032448 | 0.147493 |
Anticancer activity of C. limon extracts.
| Blank | Untreated | Cisplatin 15 µg/mL | 100 µg/mL | 200 µg/mL | 300 µg/mL | 400 µg/mL | 500 µg/mL | |
|---|---|---|---|---|---|---|---|---|
| Reading 1 | 0.009 | 0.63 | 0.068 | 0.365 | 0.21 | 0.194 | 0.02 | 0.008 |
| Reading 2 | 0.005 | 0.69 | 0.068 | 0.367 | 0.204 | 0.182 | 0.022 | 0.007 |
| Mean OD | 0.007 | 0.66 | 0.068 | 0.366 | 0.207 | 0.188 | 0.021 | 0.007 |
| Mean OD-Mean blank | 0.653 | 0.061 | 0.359 | 0.2 | 0.181 | 0.014 | 0.0005 | |
| Standard deviation | 0.04 | 0 | 0.001 | 0.004 | 0.008 | 0.001 | 0 | |
| Standard Error | 0.03 | 0 | 0.001 | 0.003 | 0.006 | 0.001 | 0.0005 | |
| % Standard error | 4.59 | 0 | 0.15 | 0.45 | 0.91 | 0.15 | 0.07 | |
| % Viability | 100 | 9.34 | 54.97 | 30.62 | 27.71 | 2.14 | 0.076 |
Figure 7Inhibition kinetics of amylase activity.
Figure 8Inhibition kinetics of α-glucosidase activity.
Figure 9Inhibition kinetics of urease activity.